The Latest Cardiac and Vascular News
MARLBOROUGH, Mass.–(BUSINESS WIRE)–GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to remove hypersensitivity to ‘blood and blood products’ from the contraindications in its prescribing information for its product OptisonTM (Perflutren Protein-Type A […]
Leverages the latest technologies to simplify processes with Effortless Workflow, a new artificial intelligence (AI) suite that reduces the number of clicks necessary to execute a CT exam by 66%i and helps clinicians deliver more personalized medicine – optimizing scan range […]
The multi-year strategic partnership will enable GenesisCare to offer patients greater access to leading technology, with a plan to explore further collaborations to improve cancer diagnosis, treatment and cardiovascular care The agreement is valued at more than USD 130 million […]
CHICAGO–(BUSINESS WIRE)–GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid1 cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of […]
Key Highlights Osprey Medical has received European CE Marking approval for the 2nd generation DyeVert Power XT device Approval of DyeVert Power XT (for automatic injection) means the full coronary angiography market is now available to Osprey’s DyeVert franchise Device is […]
Edison AI platform will integrate with ACR AI-LABTM, providing ACR members and other radiology professionals with connectivity to valuable Edison AI services Among the 100+ GE Healthcare AI developer services on Edison is a tool that tracks the source and […]
WASHINGTON–(BUSINESS WIRE)–GE Healthcare and HeartFlow, Inc. announced today at SCCT2017, the annual scientific meeting of the Society of Cardiovascular Computed Tomography, that they have entered into a global collaboration agreement with the goal of increasing the clinical availability and adoption of HeartFlow […]
